Synthesis and Biological Evaluation of Cyclobutane-Based ß3 Integrin Antagonists: A Novel Approach to Targeting Integrins for Cancer Therapy. (2023)

First Author: Sutherland M
Attributed to:  Design, synthesis and applications of chiral cyclobutanes funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/cancers15164023

PubMed Identifier: 37627051

Publication URI: http://europepmc.org/abstract/MED/37627051

Type: Journal Article/Review

Volume: 15

Parent Publication: Cancers

Issue: 16

ISSN: 2072-6694